Phase 4 is post FDA approval collection of data.
Ann: Media release - First stroke patient with afamelanotide, page-20
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.76 |
Change
0.505(4.49%) |
Mkt cap ! $586.4M | |||
| Open | High | Low | Value | Volume |
| $11.25 | $11.77 | $11.14 | $603.7K | 52.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 374 | $11.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.77 | 226 | 2 |
View Market Depth
| Last trade - 13.37pm 21/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |